Ray Dalio's ACHC Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 171,288 shares of Acadia Healthcare Company, Inc. (ACHC) worth $2.43 M, representing 0.01% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in ACHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 90,978 shares. Largest reduction occurred in Q2 2024, reducing 64,347 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Acadia Healthcare Company (ACHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Acadia Healthcare Company (ACHC) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +80,310 | Add 88.27% | 171,288 | $14.19 |
| Q3 2025 | +90,978 | New Buy | 90,978 | $24.76 |
| Q1 2025 | -9,894 | Sold Out | 0 | $0.00 |
| Q4 2024 | -5,338 | Reduce 35.04% | 9,894 | $39.65 |
| Q3 2024 | -3,772 | Reduce 19.85% | 15,232 | $63.41 |
| Q2 2024 | -64,347 | Reduce 77.20% | 19,004 | $67.54 |
| Q1 2024 | -13,529 | Reduce 13.96% | 83,351 | $79.22 |
| Q4 2023 | +46,372 | Add 91.81% | 96,880 | $77.76 |
| Q3 2023 | -47,113 | Reduce 48.26% | 50,508 | $70.31 |
| Q2 2023 | -10,457 | Reduce 9.68% | 97,621 | $79.64 |
| Q1 2023 | +9,555 | Add 9.70% | 108,078 | $72.25 |
| Q4 2022 | -39,992 | Reduce 28.87% | 98,523 | $82.32 |
| Q3 2022 | -107 | Reduce 0.08% | 138,515 | $78.18 |
| Q2 2022 | +43,688 | Add 46.02% | 138,622 | $67.63 |
| Q1 2022 | +46,394 | Add 95.58% | 94,934 | $65.53 |
| Q4 2021 | +42,374 | Add 687.22% | 48,540 | $60.69 |
| Q3 2021 | +6,166 | New Buy | 6,166 | $63.74 |
Ray Dalio's Acadia Healthcare Company Investment FAQs
Ray Dalio first purchased Acadia Healthcare Company, Inc. (ACHC) in Q3 2021, acquiring 6,166 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Acadia Healthcare Company, Inc. (ACHC) for 17 quarters since Q3 2021.
Ray Dalio's largest addition to Acadia Healthcare Company, Inc. (ACHC) was in Q3 2025, adding 90,978 shares worth $2.25 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 171,288 shares of Acadia Healthcare Company, Inc. (ACHC), valued at approximately $2.43 M.
As of the Q4 2025 filing, Acadia Healthcare Company, Inc. (ACHC) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Acadia Healthcare Company, Inc. (ACHC) was 171,288 shares, as reported at the end of Q4 2025.